# Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer

> **NCT00898924** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 60 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** molecular diagnostic method
- **GENETIC:** mutation analysis

## Key facts

- **NCT ID:** NCT00898924
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-03
- **Final completion:** 2010-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898924, "Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00898924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*